Early MRI endpoints provide a valid measure of structural damage while reducing study duration and participant numbers in rheumatoid arthritis clinical trials.

J. Baker, P.G. Conaghan, P. Emery, D. Baker, Mikkel Østergaard

Original languageEnglish
JournalArthritis & Rheumatology
Volume66
Issue numberSuppl. 11
Pages (from-to)S832
Number of pages1
ISSN1537-2960
Publication statusPublished - 2014

Cite this